Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences
AffiliationUniv Arizona, Pathogen & Microbiome Inst
MetadataShow full item record
PublisherBIOMED CENTRAL LTD
CitationCompositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences 2017, 5 (1) Microbiome
Rights© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractBackground: Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by persistent sinonasal inflammation and sinus microbiome dysbiosis. The basis of this heterogeneity is poorly understood. We sought to address the hypothesis that a limited number of compositionally distinct pathogenic bacterial microbiota exist in CRS patients and invoke discrete immune responses and clinical phenotypes in CRS patients. Results: Sinus brushings from patients with CRS (n = 59) and healthy individuals (n = 10) collected during endoscopic sinus surgery were analyzed using 16S rRNA gene sequencing, predicted metagenomics, and RNA profiling of the mucosal immune response. We show that CRS patients cluster into distinct sub-groups (DSI-III), each defined by specific pattern of bacterial co-colonization (permutational multivariate analysis of variance (PERMANOVA); p = 0.001, r(2) = 0.318). Each sub-group was typically dominated by a pathogenic family: Streptococcaceae (DSI), Pseudomonadaceae (DSII), Corynebacteriaceae [DSIII(a)], or Staphylococcaceae [DSIII(b)]. Each pathogenic microbiota was predicted to be functionally distinct (PERMANOVA; p = 0.005, r(2) = 0.217) and encode uniquely enriched gene pathways including ansamycin biosynthesis (DSI), tryptophan metabolism (DSII), two-component response [DSIII(b)], and the PPAR-gamma signaling pathway [DSIII(a)]. Each is also associated with significantly distinct host immune responses; DSI, II, and III(b) invoked a variety of pro-inflammatory, T(H)1 responses, while DSIII(a), which exhibited significantly increased incidence of nasal polyps (Fisher's exact; p = 0.034, relative risk = 2.16), primarily induced IL-5 expression (Kruskal Wallis; q = 0.045). Conclusions: A large proportion of CRS patient heterogeneity may be explained by the composition of their sinus bacterial microbiota and related host immune response-features which may inform strategies for tailored therapy in this patient population.
VersionFinal published version
SponsorsCystic Fibrosis Foundation Award
- Sinus microbiota varies among chronic rhinosinusitis phenotypes and predicts surgical outcome.
- Authors: Ramakrishnan VR, Hauser LJ, Feazel LM, Ir D, Robertson CE, Frank DN
- Issue date: 2015 Aug
- Evidence of microbiota dysbiosis in chronic rhinosinusitis.
- Authors: Hoggard M, Biswas K, Zoing M, Wagner Mackenzie B, Taylor MW, Douglas RG
- Issue date: 2017 Mar
- Changes in the bacterial microbiome of patients with chronic rhinosinusitis after endoscopic sinus surgery.
- Authors: Jain R, Hoggard M, Biswas K, Zoing M, Jiang Y, Douglas R
- Issue date: 2017 Jan
- Mapping and comparing bacterial microbiota in the sinonasal cavity of healthy, allergic rhinitis, and chronic rhinosinusitis subjects.
- Authors: Lal D, Keim P, Delisle J, Barker B, Rank MA, Chia N, Schupp JM, Gillece JD, Cope EK
- Issue date: 2017 Jun
- Impact of cigarette smoking on the middle meatus microbiome in health and chronic rhinosinusitis.
- Authors: Ramakrishnan VR, Frank DN
- Issue date: 2015 Nov